Related Experiment Video
Updated: Sep 23, 2025

07:07
Analysis of Learning and Memory Ability in an Alzheimer's Disease Mouse Model using the Morris Water Maze
Published on: October 29, 2019
19.4K
Catalpol Alleviates Isoflurane-Induced Hippocampal Learning and Memory Dysfunction and Neuropathological Changes in
Weiqing Shi1, Wenbing Zhang2, Jinping Wang1
1Department of Anesthesiology, Jincheng People's Hospital, Jincheng, China.
Neuroimmunomodulation
|May 11, 2022
Summary
Catalpol preconditioning effectively protected aged mice against isoflurane-induced neurocognitive disorders. It alleviated cognitive decline and neuropathological damage by suppressing the NLRP3 inflammatory pathway.
Area of Science:
- Neuroscience
- Pharmacology
- Gerontology
Background:
- Isoflurane anesthesia can cause perioperative neurocognitive disorders (PNDs) in elderly patients, often involving hippocampal dysfunction and inflammation.
- Catalpol, a natural compound, shows potential neuroprotective and neurotransmission-modulating properties.
Purpose of the Study:
- To investigate the potential protective effects of catalpol against isoflurane-induced PNDs in aged mice.
- To elucidate the underlying mechanisms involving neuroprotection and the NLRP3 inflammasome pathway.
Main Methods:
- Aged mice were preconditioned with catalpol before isoflurane exposure to model PNDs.
- A comprehensive battery of behavioral, histological, biochemical, electrophysiological, and immunofluorescent assays were conducted.
Main Results:
- Catalpol preadministration significantly improved cognitive functions in behavioral tests (Morris water maze, novel object recognition, Y-maze).
- It reduced neuronal and synaptic loss, restoring hippocampal synaptic plasticity.
- Catalpol suppressed microglial activation and decreased NLRP3 inflammasome expression.
Conclusions:
- Catalpol effectively alleviates cognitive impairment and neuropathological damage in aged mice exposed to isoflurane.
- Its neuroprotective effects are mediated through the modulation of the NLRP3 inflammatory pathway.

